iSpecimen Inc (ISPC): Kapitalisasi marang pendapatan

Tandha merek iSpecimen Corp (ISPC)

The stability of iSpecimen Inc. (ISPC) is underpinned by its streamlined online logistics for biomaterials, as evidenced by the current P/S ratio, which stands at 3.70. The company has developed a unique tissue marketplace to accelerate pharmacological research. However, national digital sovereignty and technological nationalism could limit the global expansion of iSpecimen Inc. (ISPC) software, creating risks of business fragmentation.

ISPC Rasio rega marang pendapatan iSpecimen Corp (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan iSpecimen Inc. (ISPC)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:iSpecimen Inc (ISPC)
Produk dadi iSpecimen Inc

The P/S ratio determines the market value of a business relative to its operating revenues, eliminating the impact of accounting manipulations regarding profit. By analyzing the price-to-sales ratio, an investor assesses the premium the market is willing to pay for every dollar of sales. This metric measures the efficiency of market share monetization and the pace of revenue scaling. For iSpecimen Inc. (ISPC), this indicator reflects the capitalization of the scientific community's trust in its unique biomaterials marketplace.

Perusahaan pesaing

Koefisien rega marang pendapatan veeva.com|Rasio rega marang pendapatan Doximity DOCS|HQY - Kapitalisasi marang pendapatan|Waystar Inc. - Multiplikator P/S|Rega marang dodolan CorVel Corp.|Privia Health Group (PRVA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan HURN|Kapitalisasi marang pendapatan CERT|OMCL: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S GDRX|Koefisien rega marang pendapatan Schrodinger Corp|Rasio rega marang pendapatan Phreesia, Inc. PHR|OMDA: Rasio kapitalisasi marang pendapatan|Evolent Health - Multiplikator P/S|HealthStream Inc (HSTM) - Kapitalisasi marang pendapatan|DH (Definitive Healthcare Inc.) - Kapitalisasi marang pendapatan|CCSI - Koefisien rega marang pendapatan|AGL (Agilon Health) - Multiplikator P/S|absci.com (ABSI) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan So-Young International Inc. (SY)|Koefisien rega marang pendapatan NRC Health|Rasio rega marang pendapatan Spok Corp SPOK|OPRX (OptimizeRx Inc.) - Rasio rega marang dodolan|TruBridge, Inc. - Multiplikator P/S|simulations-plus.com (SLP) - Kapitalisasi marang pendapatan|SOPH: Multiplikator P/S|HCAT - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan CCLD|RSSS (Research Solutions Inc.) - Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Scienture SCNX|HCTI - Kapitalisasi marang pendapatan|Bullfrog AI Holdings Inc - Multiplikator P/S|Rega marang dodolan SCWorx Inc|MSPR: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ICCT|MEDS (TRxADE HEALTH) - Multiplikator P/S|Orgenesis Inc (ORGS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan R1 RCM Inc. (RCM)|Koefisien rega marang pendapatan Sharecare Inc|Rasio rega marang pendapatan Streamline Health Solutions STRM|SYRA (syrahealth.com) - Rasio rega marang dodolan|ApolloMed - Multiplikator P/S|Rega marang dodolan Model N Inc|NXGN: Multiplikator P/S